Kurrajong Natural Medicine Centre

We Take Care of Your Health Naturally, Using Traditional Chinese Medicine, Acupuncture and Western Herbal Medicine, Diet and Body Therapies.

Kurrajong Natural Medicine Centre Logo
For Face-to-Face or Telehealth Appointments, Please Call: 0492 814 971  or (02) 45730784 

Traditional Chinese Medicine (TCM) in Cancer Care

The Role of Traditional Chinese Medicine in Cancer Care​

Cancer remains one of the most formidable health challenges globally, with conventional treatments like chemotherapy, radiotherapy, and surgery often producing severe side effects that compromise patients’ quality of life. As cancer care evolves toward more integrative approaches, Traditional Chinese Medicine in cancer care has emerged as a complementary therapy with growing evidence for supporting cancer patients. This article critically examines TCM’s role in three crucial areas: managing treatment-related side effects, supporting mental health, and inhibiting cancer metastasis.

Managing Treatment-Related Side Effects

One of the most compelling applications of TCM in oncology lies in mitigating the debilitating side effects of conventional cancer treatments. Chemotherapy and radiotherapy, while targeting cancer cells, frequently damage healthy tissues, leading to bone marrow suppression, severe nausea and vomiting, fatigue, and organ dysfunction. Research indicates that TCM, particularly Chinese herbal medicine, can significantly reduce these adverse effects when used alongside standard treatments.

Multiple clinical studies have demonstrated the effectiveness of traditional Chinese medicine in cancer care with respect to addressing chemotherapy-induced complications. Meta-analyses of randomised controlled trials show that Astragalus-based formulations can enhance response rates to platinum-based chemotherapy in advanced non-small-cell lung cancer while reducing toxicity. The mechanisms appear multifaceted—herbs like Astragalus membranaceus (Huang Qi) and ginseng (Ren Shen) have been shown to protect bone marrow function, helping to prevent the dangerous drop in white blood cells that often forces treatment interruptions.

Gastrointestinal side effects represent another area where the role of traditional Chinese medicine in cancer care shows promise. Studies indicate that specific herbal formulas can alleviate chemotherapy-induced nausea and vomiting through multiple pathways, including anti-inflammatory effects and regulation of the digestive system. Clinical trials examining TCM for colorectal cancer patients undergoing chemotherapy have documented reduced gastrointestinal reactions and improved tolerance to treatment.

The anti-inflammatory properties of many medicinal plant compounds also appear to protect organs from treatment-related damage. Recent research on cancer immunotherapy has revealed that TCM can help mitigate immune-related adverse reactions, which can include potentially serious conditions like immune pneumonia and hepatitis. Herbs such as resveratrol and Astragalus possess immunomodulatory properties that may prevent the immune system from attacking healthy tissues during immunotherapy while still maintaining anti-cancer effects.

Supporting Mental Health and Quality of Life

The psychological burden of cancer is profound, with patients frequently experiencing anxiety, depression, fear, and existential distress. TCM’s holistic philosophy, which views mental and physical health as inseparable, offers a distinctive approach to addressing these challenges.

TCM’s theoretical framework for mental health differs fundamentally from Western psychiatry. Rather than focusing solely on neurotransmitter imbalances, TCM conceptualises emotional disturbances as manifestations of energetic imbalances in specific organ systems. Anxiety may be attributed to Heart and Liver disharmonies, while depression might reflect deficiencies in Spleen Qi or Kidney Yang. This holistic perspective allows TCM practitioners to address both physical symptoms and emotional states simultaneously.

Several TCM modalities show evidence for mental health benefits. Acupuncture has demonstrated efficacy in reducing anxiety and depression in cancer patients, potentially through modulation of the nervous system and enhancement of endorphin release. Research on mind-body practices like Yoga, Qigong and Tai Chi reveals that these gentle movement therapies can promote relaxation, reduce stress, and improve emotional well-being in cancer populations.

Chinese herbal medicine also plays a role in psychological support. Herbs such as Suan Zao Ren (Ziziphus jujuba) and formulas designed to “nourish the Heart and calm the Spirit” have been traditionally used to relieve anxiety and improve sleep. Qualitative research with cancer patients indicates that the patient-centred approach of TCM—including active listening, therapeutic alliance, and individualised treatment—contributes significantly to psychological well-being and perceived quality of care.

The concept of emotional care in TCM, documented in ancient texts like the Yellow Emperor’s Inner Canon, emphasises the importance of maintaining mental equilibrium for disease prevention and recovery. This approach resonates with modern integrative oncology’s recognition that addressing psychological needs is essential for optimal outcomes. Studies suggest that TCM practitioners’ emphasis on holistic regulation of mentality, nutrition, and physical fitness can promote both physical and psychological recovery during cancer treatment.

Inhibiting Cancer Metastasis

Perhaps one of the most promising areas of traditional Chinese medicine in cancer care is in regards to its role in oncology with respect to its potential to prevent or inhibit cancer metastasis, the primary cause of cancer-related deaths. Emerging preclinical evidence suggests multiple mechanisms through which TCM compounds may interfere with the metastatic cascade.

Laboratory studies have identified several pathways through which TCM may inhibit metastasis. Certain herbal remedies appear capable of regulating cancer cell proliferation, apoptosis, adhesion, and migration. Curcumin, derived from turmeric, has been shown to suppress cancer-associated fibroblasts, reducing migration and metastasis in pancreatic cancer models. Berberine demonstrates ability to inhibit cell proliferation and invasion in multiple cancer types through modulation of signalling pathways like STAT3.

Recent research has focused on TCM’s effects on the pre-metastatic niche—the prepared microenvironment in distant organs that facilitates cancer cell colonisation. Studies indicate that compounds like Astragalus polysaccharides and Polyphyllin VII may inhibit the formation of lung pre-metastatic niches by modulating immune cells, reducing inflammation, and preventing the molecular changes that make tissues hospitable to metastatic cells. TCM formulas like Shi Juan Da Bu Wan have been reported to reduce metastatic potential in animal models through activation of natural killer cells and enhanced tumour necrosis factor secretion.

Epithelial-mesenchymal transition (EMT), a process allowing cancer cells to acquire invasive properties, represents another potential target. Research suggests that compounds in plants, including curcumin and resveratrol, can reverse EMT in various cancer types, restoring epithelial characteristics and reducing metastatic capability. Additionally, some TCM herbal formulas appear to modulate tumour-associated macrophages, reprogramming them from an immunosuppressive M2-like phenotype to an immunostimulatory M1-like phenotype that inhibits cancer spread.

TCM’s approach to preventing metastasis aligns with its traditional theory of “strengthening vital Qi to eliminate pathogens.” The concept holds that cancer metastasises to sites where “positive Qi is deficient,” and that tonifying Qi and blood while regulating Yin-Yang balance can create an internal environment resistant to tumour infiltration.

It is important to understand that the use of TCM does not and is not intended to be a substitute for orthodox medical treatment, however, research clearly illustrates that used in combination TCM offers significant potential support on a therapeutic, physical, mental and emotional level.

Traditional Chinese Medicine in Cancer Care: Conclusion

Traditional Chinese Medicine in cancer care demonstrates genuine potential for supporting cancer patients, particularly in managing treatment side effects and contributing to holistic wellbeing. The evidence for reducing chemotherapy and radiotherapy toxicity appears promising. TCM’s holistic approach to mental health aligns with contemporary understanding of the interconnection between psychological and physical health in cancer recovery.

References for “The Role of Traditional Chinese Medicine in Cancer Care”

Side-Effect Management and Chemotherapy

  1. McCulloch, M., See, C., Shu, X. J., Broffman, M., Kramer, A., Fan, W. Y., Gao, J., Lieb, W., Shieh, K., & Colford, J. M. (2006). Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials. Journal of Clinical Oncology, 24(3), 419-430. https://doi.org/10.1200/JCO.2005.03.6392
  2. Peng, W., & Meng, X. (2010). Astragalus-containing Chinese herbal combinations for advanced non-small-cell lung cancer: A meta-analysis of 65 clinical trials enrolling 4751 patients. Lung Cancer: Targets and Therapy, 2010(1), 85-107.
  3. Zhang, H. W., Lin, Z. X., Xu, C., Leung, C., & Chan, L. S. (2019). Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis. Medicine, 98(13), e14798. https://doi.org/10.1097/MD.0000000000014798

Metastasis Inhibition – Curcumin

  1. Wang, Q., Qu, C., Xie, F., Chen, L., Liu, L., Liang, X., Wu, X., Wang, P., & Meng, Z. (2017). Curcumin suppresses epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells by inhibiting cancer-associated fibroblasts. American Journal of Cancer Research, 7(1), 125-133.
  2. Qu, C., Wang, Q., & Meng, Z. (2018). Cancer-associated fibroblasts in pancreatic cancer: Should they be deleted or reeducated? Integrative Cancer Therapies, 17(4), 1016-1019. https://doi.org/10.1177/1534735418794884
  3. Iranshahi, M., Sahebkar, A., Hosseini, S. T., Takasaki, M., Konoshima, T., & Tokuda, H. (2021). Antimetastatic effects of curcumin in oral and gastrointestinal cancers. Frontiers in Pharmacology, 12, 668567. https://doi.org/10.3389/fphar.2021.668567
  4. Ataei, S., Jafari, A., Asghari, A., Asgari Taei, A., Pezeshkian, M., & Alipourfard, I. (2023). Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by curcumin in breast cancer therapy. Scientific Reports, 13, 20336. https://doi.org/10.1038/s41598-023-48073-w
  5. Tavakol, S., Ashrafizadeh, M., Deng, S., Azarian, M., Abdoli, A., Motavaf, M., Poormoghadam, D., Khanbabaei, H., Ghasemipour Afshar, E., Mandegary, A., Pardakhty, A., Sethi, G., Zarrabi, A., & Sharifi, E. (2019). Curcumin: A potent agent to reverse epithelial-to-mesenchymal transition. Cellular Oncology, 42, 405-421. https://doi.org/10.1007/s13402-019-00442-2
  6. Ashrafizadeh, M., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Bagherian, M., Azami, N., Bejandi, A. K., Hushmandi, K., Ang, H. L., Sethi, G., Kumar, A. P., Ahn, K. S., Najafi, M., & Mohammadinejad, R. (2021). The role of curcumin in cancer treatment. Biomedicines, 9(9), 1188. https://doi.org/10.3390/biomedicines9091188
  7. Liu, Y., Zeng, S., Jiang, X., Lai, D., & Su, Z. (2021). Curcumin regulates cancer progression: Focus on ncRNAs and molecular signaling pathways. Frontiers in Oncology, 11, 660712. https://doi.org/10.3389/fonc.2021.660712

Metastasis Inhibition – Berberine

  1. Zahra, K., Patel, S., Dey, T., Pandey, U., & Mishra, S. P. (2022). Berberine: An important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules, 27(18), 5889. https://doi.org/10.3390/molecules27185889
  2. Li, Y., Liu, Y., Peng, X., Liu, W., Zhao, F., & Feng, Y. (2015). Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway. PLOS ONE, 10(5), e0123478. https://doi.org/10.1371/journal.pone.0123478
  3. Chen, J., Wang, W., Shi, C., & Fang, J. (2021). Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p. Biochemical and Biophysical Research Communications, 557, 234-241. https://doi.org/10.1016/j.bbrc.2021.04.018
  4. Wang, N., Tan, H. Y., Li, S., Xu, Y., Guo, W., & Feng, Y. (2015). Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. BMC Complementary and Alternative Medicine, 15, 18. https://doi.org/10.1186/s12906-015-0541-x
  5. Zhao, X., Liu, L., Wang, F., Zhao, L., Sun, Q., Chen, D., Hao, Y., Jin, Z., Li, G., & Liu, J. (2025). Berberine hydrochloride inhibits the proliferation and metastasis of p53 mutant gallbladder cancer cells by regulating the IL6/STAT3 pathway. Scientific Reports, 15, 1695. https://doi.org/10.1038/s41598-025-11480-2
  6. Ahmad, I., Paudel, Y. N., & Kumar, S. (2022). Multi-target potential of berberine as an antineoplastic and antimetastatic agent: A special focus on lung cancer treatment. Cells, 11(21), 3433. https://doi.org/10.3390/cells11213433
  7. Imenshahidi, M., & Hosseinzadeh, H. (2021). Berberine as a potential anticancer agent: A comprehensive review. Biomedicine & Pharmacotherapy, 144, 112353. https://doi.org/10.1016/j.biopha.2021.112353

Mental Health and Quality of Life – Acupuncture

  1. Huang, X., Wang, Y., Zeng, Y., Wu, Y., Liang, H., Huang, S., Mo, L., Wu, S., Liang, F., He, J., Wang, H., Wu, P., & Lan, Y. (2024). Efficacy of acupuncture for depression: A systematic review and meta-analysis. Frontiers in Neuroscience, 18, 1347651. https://doi.org/10.3389/fnins.2024.1347651
  2. Wang, Y., Liu, Z., Wang, F., Wang, C., Li, X., Zeng, Y., Zhang, H., Yu, Y., Li, M., Chen, S., & Shen, X. (2022). Acupuncture and acupressure with improved cancer-related depression of retrospective studies. Frontiers in Oncology, 12, 1036634. https://doi.org/10.3389/fonc.2022.1036634
  3. Zhang, Y., Lin, L., Li, H., Hu, Y., & Tian, L. (2023). Effects of somatic acupoint stimulation on anxiety and depression in cancer patients: An updated systematic review of randomized controlled trials. Complementary Therapies in Medicine, 73, 102937. https://doi.org/10.1016/j.ctim.2023.102937
  4. Garland, S. N., Xie, S. X., DuHamel, K. N., Bao, T., Li, Q. S., Barg, F. K., Jao, Y. L., & Mao, J. J. (2024). Acupuncture versus cognitive behavioral therapy for anxiety among cancer survivors with insomnia: An exploratory analysis of a randomized clinical trial. Journal of the National Comprehensive Cancer Network, 22(6), 564-571.
  5. Haddad, N. E., Palesh, O., Del Fabbro, E., Rosenzweig, M., & Peng, H. (2014). Acupuncture in the treatment of cancer-related psychological symptoms. Integrative Cancer Therapies, 13(5), 371-385. https://doi.org/10.1177/1534735413520181
  6. National Cancer Institute. (2024). Acupuncture (PDQ®)–Patient version. https://www.cancer.gov/about-cancer/treatment/cam/patient/acupuncture-pdq
  7. Chen, X., Li, Y., Wang, S., Zhang, L., Liu, H., & Zhao, L. (2025). Clinical efficacy study on the combined treatment of cancer-related depression with traditional Chinese acupuncture-related therapies and drugs. Frontiers in Psychiatry, 15, 1717290. https://doi.org/10.3389/fpsyt.2025.1717290

Kurrajong Natural Medicine Center will be closed from 24th Dec. 2023 to January 9th Inclusive.

We’d like to wish everyone a Merry Christmas and a Happy New Year.